Highlights Waters Corporation

Stocks

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - NYSE Other stock markets 01:30:02 13/06/2026 am IST			5-day change	1st Jan Change
355.53 ^USD	-1.17%		-2.69%	-6.40%

11/06	Piper Sandler Initiates Waters at Neutral With $400 Price Target	MT
08/06	Waters Corporation Launches BioResolve Peptide and GTxResolve Lipid Phenyl-Hexyl+ and C18+ Columns	CI

Highlights

08/06	Waters Corporation Launches BioResolve Peptide and GTxResolve Lipid Phenyl-Hexyl+ and C18+ Columns	CI
03/06	Waters Corporation Announces FDA 510(k) Clearance Of BD BACTEC FXI Culture System	CI
01/06	Waters Corporation Unveils Cyclic Ims P20 Ms	CI
01/06	Waters Corporation Introduces Xevo Mrt P10 Mass Spectrometer with Enhanced Sensitivity and Speed	CI
05/05	Waters Corporation Reports Earnings Results for the First Quarter Ended April 04, 2026	CI
05/05	Waters raises annual profit forecast as biosciences unit drives growth	RE
05/05	Waters Fiscal Q1 Adjusted Earnings, Revenue Increase; 2026 Adjusted EPS Guidance Lifted	MT
05/05	(WAT) Waters Corporation Expects Q2 Revenue Range $1.62B - $1.63B	MT
05/05	(WAT) Waters Corporation Expects Q2 Adjusted EPS Range $2.95 - $3.05	MT
05/05	Earnings Flash (WAT) Waters Corporation Reports Q1 Revenue $1.27B, vs. FactSet Est of $1.20B	MT
05/05	Earnings Flash (WAT) Waters Corporation Posts Q1 Adjusted EPS $2.70 per Share, vs. FactSet Est of $2.31	MT
05/05	Waters Corporation Provides Earnings Guidance for the Second Quarter Ending July 4, 2026 and Full Year Ending December 31, 2026	CI
05/05	Waters Corporation Raises Earnings Guidance for the Full Year Ending December 31, 2026	CI
14/04	Waters Corporation Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC Powering Rapid Characterization of Large Molecules	CI
08/04	US FDA approves Waters' at-home cervical cancer screening kit	RE
08/04	Waters Corporation Announces U.S. Food and Drug Administration Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay	CI
09/03	Waters Corporation Launches ARES-G3 Rheometer	CI
23/02	Tranche Update on Waters Corporation's Equity Buyback Plan announced on January 23, 2019.	CI
10/02	Sector Update: Health Care Stocks Fall Late Afternoon	MT
10/02	Top Midday Decliners	MT
10/02	Top Middle Decliners	MT
09/02	Waters Corporation completed the acquisition of Biosciences and Diagnostics Solutions Business of Becton, Dickinson and Company in a transaction valued at $18.8 billion.	CI
09/02	Waters Corporation Announces Establishment of Four Divisions	CI
09/02	Waters forecasts weak first-quarter profit, shares slide	RE
09/02	Waters Completes Merger With Becton, Dickinson's Biosciences, Diagnostic Solutions Business	MT